| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $31.0M | +41.0% |
| SG&A Expense | $11.0M | +13.9% |
| Operating Income | -$42.0M | -14.3% |
| Interest Expense | $2.7M | +5552.5% |
| Pre-tax Income | -$43.8M | -19.0% |
| Income Tax | $0 | — |
| Net Income | -$43.8M | -19.0% |
| EPS (Basic) | -$3.38 | -2153.3% |
| EPS (Diluted) | -$3.38 | -2153.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.6M | -73.1% |
| Current Assets | $33.0M | -33.9% |
| Total Assets | $33.1M | -33.9% |
| Current Liabilities | $30.7M | +263.0% |
| Total Liabilities | $30.7M | +258.8% |
| Stockholders' Equity | $2.4M | -94.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.2M | -26.3% |
| Capital Expenditures | $3K | -77.2% |
| Investing Cash Flow | -$3K | +99.9% |
| Financing Cash Flow | $19.9M | -51.5% |
| Free Cash Flow | -$37.2M | -26.3% |